Julien Boone, the Global Head of Oncology Asset Strategy at Servier, announced plans to attend the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid. In a recent LinkedIn post, Boone expressed excitement about the upcoming event.
Boone will be accompanied by a team that includes Ibtissam Marchiq, Fanny Cazade, Kristin Horton, and Zakia Rahhali Felloussi. He mentioned that the congress will provide an opportunity for intense discussions on science and innovation within the field of oncology.
“For us, ESMO is more than a congress. It’s a place to challenge our thinking, connect with the oncology community, explore emerging science and opportunities, and bring fresh perspectives back to our portfolio and our patients,” Boone stated.
He highlighted the team’s energy, curiosity, and dedication to oncology, which he believes will enhance the experience of attending the congress. Boone also encouraged others attending the event to connect with him and his team, emphasizing their interest in exchanging ideas about the future of cancer treatments.
ESMO 2026 is set to be a significant event for professionals in oncology, marking another step in the ongoing dialogue regarding advancements in cancer medicine.


